Logo image of ICOS.MI

INTERCOS SPA (ICOS.MI) Stock Fundamental Analysis

BIT:ICOS - Euronext Milan - IT0005455875 - Common Stock - Currency: EUR

13.4  +0.28 (+2.13%)

Fundamental Rating

4

Taking everything into account, ICOS scores 4 out of 10 in our fundamental rating. ICOS was compared to 14 industry peers in the Personal Care Products industry. While ICOS seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ICOS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ICOS was profitable.
In the past year ICOS had a positive cash flow from operations.
ICOS had positive earnings in each of the past 5 years.
In the past 5 years ICOS always reported a positive cash flow from operatings.
ICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFICOS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

1.2 Ratios

ICOS has a Return On Assets (4.47%) which is comparable to the rest of the industry.
ICOS has a Return On Equity (10.11%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 11.79%, ICOS perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ICOS is below the industry average of 11.55%.
The last Return On Invested Capital (11.79%) for ICOS is above the 3 year average (9.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.47%
ROE 10.11%
ROIC 11.79%
ROA(3y)4.28%
ROA(5y)4.65%
ROE(3y)10.02%
ROE(5y)12.49%
ROIC(3y)9.12%
ROIC(5y)9.57%
ICOS.MI Yearly ROA, ROE, ROICICOS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

ICOS has a Profit Margin of 4.51%. This is in the lower half of the industry: ICOS underperforms 61.54% of its industry peers.
In the last couple of years the Profit Margin of ICOS has declined.
ICOS's Operating Margin of 8.72% is on the low side compared to the rest of the industry. ICOS is outperformed by 76.92% of its industry peers.
In the last couple of years the Operating Margin of ICOS has declined.
Looking at the Gross Margin, with a value of 19.61%, ICOS is doing worse than 76.92% of the companies in the same industry.
ICOS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.72%
PM (TTM) 4.51%
GM 19.61%
OM growth 3Y5.36%
OM growth 5Y-2.46%
PM growth 3Y-5.79%
PM growth 5Y-5%
GM growth 3Y-0.48%
GM growth 5Y-2.03%
ICOS.MI Yearly Profit, Operating, Gross MarginsICOS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 5 10 15 20

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ICOS is still creating some value.
The number of shares outstanding for ICOS remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ICOS has more shares outstanding
Compared to 1 year ago, ICOS has an improved debt to assets ratio.
ICOS.MI Yearly Shares OutstandingICOS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
ICOS.MI Yearly Total Debt VS Total AssetsICOS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

ICOS has an Altman-Z score of 3.16. This indicates that ICOS is financially healthy and has little risk of bankruptcy at the moment.
ICOS has a Altman-Z score of 3.16. This is in the better half of the industry: ICOS outperforms 61.54% of its industry peers.
ICOS has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
The Debt to FCF ratio of ICOS (1.25) is better than 92.31% of its industry peers.
ICOS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
ICOS's Debt to Equity ratio of 0.10 is amongst the best of the industry. ICOS outperforms 92.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.25
Altman-Z 3.16
ROIC/WACC1.54
WACC7.64%
ICOS.MI Yearly LT Debt VS Equity VS FCFICOS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.10 indicates that ICOS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.10, ICOS is in line with its industry, outperforming 53.85% of the companies in the same industry.
A Quick Ratio of 0.66 indicates that ICOS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.66, ICOS is doing worse than 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.66
ICOS.MI Yearly Current Assets VS Current LiabilitesICOS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The earnings per share for ICOS have decreased strongly by -12.54% in the last year.
The Earnings Per Share has been growing slightly by 1.17% on average over the past years.
ICOS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.57%.
ICOS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.40% yearly.
EPS 1Y (TTM)-12.54%
EPS 3Y9.52%
EPS 5Y1.17%
EPS Q2Q%-28.96%
Revenue 1Y (TTM)4.57%
Revenue growth 3Y17.67%
Revenue growth 5Y7.4%
Sales Q2Q%2.36%

3.2 Future

Based on estimates for the next years, ICOS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.90% on average per year.
Based on estimates for the next years, ICOS will show a small growth in Revenue. The Revenue will grow by 2.50% on average per year.
EPS Next Y4.64%
EPS Next 2Y11.54%
EPS Next 3Y12.36%
EPS Next 5Y11.9%
Revenue Next Year7.26%
Revenue Next 2Y7.52%
Revenue Next 3Y7.28%
Revenue Next 5Y2.5%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICOS.MI Yearly Revenue VS EstimatesICOS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ICOS.MI Yearly EPS VS EstimatesICOS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6 0.8

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.51, which means the current valuation is very expensive for ICOS.
Compared to the rest of the industry, the Price/Earnings ratio of ICOS is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 29.35, ICOS is valued at the same level.
The Price/Forward Earnings ratio is 17.80, which indicates a rather expensive current valuation of ICOS.
ICOS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ICOS is cheaper than 69.23% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ICOS to the average of the S&P500 Index (22.10), we can say ICOS is valued inline with the index average.
Industry RankSector Rank
PE 28.51
Fwd PE 17.8
ICOS.MI Price Earnings VS Forward Price EarningsICOS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

76.92% of the companies in the same industry are more expensive than ICOS, based on the Enterprise Value to EBITDA ratio.
61.54% of the companies in the same industry are cheaper than ICOS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 30.11
EV/EBITDA 9.01
ICOS.MI Per share dataICOS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ICOS does not grow enough to justify the current Price/Earnings ratio.
ICOS's earnings are expected to grow with 12.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)6.14
PEG (5Y)24.47
EPS Next 2Y11.54%
EPS Next 3Y12.36%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.50%, ICOS has a reasonable but not impressive dividend return.
ICOS's Dividend Yield is slightly below the industry average, which is at 2.32.
ICOS's Dividend Yield is slightly below the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 1.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

42.88% of the earnings are spent on dividend by ICOS. This is a bit on the high side, but may be sustainable.
DP42.88%
EPS Next 2Y11.54%
EPS Next 3Y12.36%
ICOS.MI Yearly Income VS Free CF VS DividendICOS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
ICOS.MI Dividend Payout.ICOS.MI Dividend Payout, showing the Payout Ratio.ICOS.MI Dividend Payout.PayoutRetained Earnings

INTERCOS SPA

BIT:ICOS (3/7/2025, 7:00:00 PM)

13.4

+0.28 (+2.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)05-07 2025-05-07
Inst Owners39.17%
Inst Owner ChangeN/A
Ins Owners32.2%
Ins Owner ChangeN/A
Market Cap1.29B
Analysts85.71
Price Target18.19 (35.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.5%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP42.88%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.6%
EPS NY rev (3m)-8.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-0.55%
Valuation
Industry RankSector Rank
PE 28.51
Fwd PE 17.8
P/S 1.29
P/FCF 30.11
P/OCF 13.55
P/B 2.89
P/tB 5.05
EV/EBITDA 9.01
EPS(TTM)0.47
EY3.51%
EPS(NY)0.75
Fwd EY5.62%
FCF(TTM)0.45
FCFY3.32%
OCF(TTM)0.99
OCFY7.38%
SpS10.39
BVpS4.64
TBVpS2.65
PEG (NY)6.14
PEG (5Y)24.47
Profitability
Industry RankSector Rank
ROA 4.47%
ROE 10.11%
ROCE 16.85%
ROIC 11.79%
ROICexc 15.93%
ROICexgc 31.75%
OM 8.72%
PM (TTM) 4.51%
GM 19.61%
FCFM 4.29%
ROA(3y)4.28%
ROA(5y)4.65%
ROE(3y)10.02%
ROE(5y)12.49%
ROIC(3y)9.12%
ROIC(5y)9.57%
ROICexc(3y)13.17%
ROICexc(5y)13.68%
ROICexgc(3y)24.59%
ROICexgc(5y)25.8%
ROCE(3y)13.03%
ROCE(5y)13.69%
ROICexcg growth 3Y24.46%
ROICexcg growth 5Y11.44%
ROICexc growth 3Y21.76%
ROICexc growth 5Y5.26%
OM growth 3Y5.36%
OM growth 5Y-2.46%
PM growth 3Y-5.79%
PM growth 5Y-5%
GM growth 3Y-0.48%
GM growth 5Y-2.03%
F-Score5
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.25
Debt/EBITDA 0.34
Cap/Depr 112.13%
Cap/Sales 5.23%
Interest Coverage 18.71
Cash Conversion 71.1%
Profit Quality 94.94%
Current Ratio 1.1
Quick Ratio 0.66
Altman-Z 3.16
F-Score5
WACC7.64%
ROIC/WACC1.54
Cap/Depr(3y)108.68%
Cap/Depr(5y)109.85%
Cap/Sales(3y)5.59%
Cap/Sales(5y)5.96%
Profit Quality(3y)82.87%
Profit Quality(5y)94.39%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.54%
EPS 3Y9.52%
EPS 5Y1.17%
EPS Q2Q%-28.96%
EPS Next Y4.64%
EPS Next 2Y11.54%
EPS Next 3Y12.36%
EPS Next 5Y11.9%
Revenue 1Y (TTM)4.57%
Revenue growth 3Y17.67%
Revenue growth 5Y7.4%
Sales Q2Q%2.36%
Revenue Next Year7.26%
Revenue Next 2Y7.52%
Revenue Next 3Y7.28%
Revenue Next 5Y2.5%
EBIT growth 1Y-7.51%
EBIT growth 3Y23.97%
EBIT growth 5Y4.76%
EBIT Next Year62.05%
EBIT Next 3Y26.8%
EBIT Next 5Y21.32%
FCF growth 1Y4150.5%
FCF growth 3Y-1.18%
FCF growth 5Y1.22%
OCF growth 1Y134.98%
OCF growth 3Y4.1%
OCF growth 5Y4.57%